Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …

Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in
this region have distinctive characteristics. First, fatty liver is frequently observed in …

Chronic hepatitis C virus (HCV) infection is a major cause of hepatic fibrosis and cirrhosis,
with a risk for the development of hepatocellular carcinoma (HCC). Although highly effective …

Hepatitis C virus (HCV) is a significant cause of hepatocellular carcinoma (HCC). The direct-
acting antivirals marked a new era of HCV therapy and are associated with greater than …

Hepatitis C virus hijacks many host metabolic processes in an effort to aid viral replication.
The resulting hepatic metabolic dysfunction underpins many of the hepatic and extrahepatic …

Hepatitis C virus (HCV) infection represents the major cause of chronic liver disease,
leading to a wide range of hepatic diseases, including cirrhosis and hepatocellular …

Treatment of hepatitis C with direct-acting antivirals is safe and highly efficacious, resulting
in viral clearance (sustained virological response [SVR]) in the vast majority of patients …

Summary Background The World Health Organization (WHO) set a goal to eliminate
hepatitis C (HCV) infection globally by 2030, with specific targets to reduce new viral …

Background & Aims Data are limited on the risk of de novo hepatocellular carcinoma (HCC)
in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) after …

Abstract Background and Aim Patients with chronic hepatitis C (CHC) treated with direct‐
acting antivirals (DAAs) are still at risk for developing hepatocellular carcinoma (HCC) even …